Weekly Digest – May 2025 Weekly Digest – May 2025 28 Apr 2025: Orum Therapeutics provides program update and announces drug candidate nomination Orum Therapeutics has discontinued the clinical development of ORM-5029, its HER2-targeted degrader-antibody conjugate (DAC), following an internal […]